Tyra Biosciences (TYRA) Net Cash Flow (2020 - 2026)
Quarterly Net Cash Flow fell 13.56% to $7.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$15.8 million through Mar 2026, up 89.74% year-over-year, with the annual reading at -$14.6 million for FY2025, 142.93% down from the prior year.
Tyra Biosciences filings provide 7 years of Net Cash Flow readings, the most recent being $7.6 million for Q1 2026.
- Net Cash Flow hit $7.6 million in Q1 2026 for Tyra Biosciences, down from $15.4 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $196.4 million in Q1 2024 and bottomed at -$157.6 million in Q4 2023.
- Average Net Cash Flow over 5 years is -$12.7 million, with a median of -$9.5 million recorded in 2023.
- Peak annual rise in Net Cash Flow hit 2164.34% in 2024, while the deepest fall reached 1567.48% in 2024.
- Tyra Biosciences' Net Cash Flow stood at -$12.0 million in 2022, then crashed by 1213.94% to -$157.6 million in 2023, then soared by 92.43% to -$11.9 million in 2024, then soared by 229.43% to $15.4 million in 2025, then tumbled by 50.97% to $7.6 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Net Cash Flow are $7.6 million (Q1 2026), $15.4 million (Q4 2025), and -$36.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -152.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 7.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.57 Mn |
| Mar 31, 2026 | 7.57 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Sep 30, 2025 | -36.54 Mn |
| Sep 30, 2025 | -36.54 Mn |
| Jun 30, 2025 | -2.23 Mn |
| Jun 30, 2025 | -2.23 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Dec 31, 2024 | -11.93 Mn |
| Dec 31, 2024 | -11.93 Mn |
| Sep 30, 2024 | 4.40 Mn |
| Sep 30, 2024 | 4.40 Mn |
| Jun 30, 2024 | -154.88 Mn |
| Jun 30, 2024 | -154.88 Mn |
| Mar 31, 2024 | 196.36 Mn |
| Mar 31, 2024 | 196.36 Mn |
| Dec 31, 2023 | -157.65 Mn |
| Dec 31, 2023 | -157.65 Mn |
| Sep 30, 2023 | -16.76 Mn |
| Sep 30, 2023 | -16.76 Mn |
| Jun 30, 2023 | -9.29 Mn |
| Jun 30, 2023 | -9.29 Mn |
| Mar 31, 2023 | -9.51 Mn |
| Mar 31, 2023 | -9.51 Mn |
| Dec 31, 2022 | -12.00 Mn |
| Dec 31, 2022 | -12.00 Mn |
| Sep 30, 2022 | -11.90 Mn |
| Sep 30, 2022 | -11.90 Mn |
| Jun 30, 2022 | -17.39 Mn |
| Jun 30, 2022 | -17.39 Mn |
| Mar 31, 2022 | -8.93 Mn |
| Mar 31, 2022 | -8.93 Mn |
| Dec 31, 2021 | -10.64 Mn |
| Dec 31, 2021 | -10.64 Mn |
| Sep 30, 2021 | 177.62 Mn |
| Sep 30, 2021 | 177.62 Mn |
| Jun 30, 2021 | -5.43 Mn |
| Jun 30, 2021 | -5.43 Mn |
| Mar 31, 2021 | 125.41 Mn |
| Mar 31, 2021 | 125.41 Mn |
| Dec 31, 2020 | -2.60 Mn |
| Dec 31, 2020 | -2.60 Mn |